Q2 2024 |
108 |
$4.66B |
+$353M |
-$624M |
-$271M |
LLY, EWTX, BSX, ISRG, BIIB
|
13F-HR |
8/14/2024, 04:06 PM |
Q1 2024 |
109 |
$5.06B |
+$671M |
-$958M |
-$287M |
LLY, EWTX, BSX, ISRG, BIIB
|
13F-HR |
5/15/2024, 04:12 PM |
Q4 2023 |
107 |
$4.62B |
+$472M |
-$837M |
-$365M |
BIIB, LLY, BSX, ISRG, EWTX
|
13F-HR |
2/14/2024, 04:14 PM |
Q3 2023 |
146 |
$4.32B |
+$595M |
-$758M |
-$163M |
BSX, HUM, ISRG, BIIB, BMRN
|
13F-HR |
11/14/2023, 04:14 PM |
Q2 2023 |
141 |
$5.11B |
+$681M |
-$519M |
+$161M |
ISRG, ELVN, BSX, THRX, BIIB
|
13F-HR |
8/14/2023, 05:25 PM |
Q1 2023 |
123 |
$5.04B |
+$786M |
-$402M |
+$384M |
SVA, ELVN, BSX, HUM, BMY
|
13F-HR |
5/15/2023, 04:41 PM |
Q4 2022 |
114 |
$5.18B |
+$449M |
-$292M |
+$157M |
SVA, UNH, BMY, BSX, HUM
|
13F-HR |
2/14/2023, 03:07 PM |
Q3 2022 |
128 |
$4.93B |
+$687M |
-$320M |
+$367M |
BMY, HUM, SWTX, BSX, BMRN
|
13F-HR |
11/14/2022, 03:11 PM |
Q2 2022 |
142 |
$5.11B |
+$279M |
-$319M |
-$40.1M |
BMY, HUM, HZNP, BSX, TPTX
|
13F-HR |
8/15/2022, 04:31 PM |
Q1 2022 |
143 |
$6.13B |
+$696M |
-$509M |
+$187M |
SWTX, HZNP, BSX, PFE, THRX
|
13F-HR |
5/16/2022, 04:17 PM |
Q4 2021 |
156 |
$7.56B |
+$983M |
-$650M |
+$333M |
SWTX, BMY, HZNP, BSX, THRX
|
13F-HR |
2/14/2022, 03:29 PM |
Q3 2021 |
167 |
$9.09B |
+$1.03B |
-$821M |
+$208M |
SWTX, PRLD, HZNP, MRK, BMY
|
13F-HR |
11/15/2021, 04:05 PM |
Q2 2021 |
154 |
$9.79B |
+$959M |
-$635M |
+$323M |
SWTX, BMY, EWTX, BSX, MRK
|
13F-HR |
8/16/2021, 04:14 PM |
Q1 2021 |
152 |
$10.6B |
+$2.46B |
-$2B |
+$461M |
SWTX, EWTX, PRLD, SPRY, HZNP
|
13F-HR |
5/17/2021, 04:16 PM |
Q4 2020 |
148 |
$11.4B |
+$2.23B |
-$591M |
+$1.64B |
PRLD, SWTX, PMVP, SPRY, ABCL
|
13F-HR |
2/16/2021, 03:43 PM |
Q3 2020 |
139 |
$7.81B |
+$1.72B |
-$353M |
+$1.36B |
PRLD, SWTX, PMVP, ALXN, TPTX
|
13F-HR |
11/16/2020, 03:12 PM |
Q2 2020 |
134 |
$7.08B |
+$1.13B |
-$722M |
+$404M |
SWTX, TCDAQ, ALXN, ASND, PRVL
|
13F-HR |
8/14/2020, 04:54 PM |
Q1 2020 |
142 |
$5.95B |
+$1.52B |
-$619M |
+$898M |
ASND, TCDAQ, ALEC, SWTX, MRK
|
13F-HR |
5/15/2020, 04:25 PM |
Q4 2019 |
135 |
$6.99B |
+$1.1B |
-$671M |
+$432M |
ASND, THOR, TCDAQ, SWTX, PRVL
|
13F-HR |
2/14/2020, 03:27 PM |
Q3 2019 |
114 |
$5.23B |
+$568M |
-$533M |
+$34.5M |
ASND, TCDAQ, BSX, ALEC, PRVL
|
13F-HR |
11/14/2019, 03:09 PM |
Q2 2019 |
127 |
$6.44B |
+$965M |
-$308M |
+$657M |
ASND, TCDAQ, BSX, ALXN, ALEC
|
13F-HR |
8/14/2019, 04:57 PM |
Q1 2019 |
124 |
$6.46B |
+$1.17B |
-$796M |
+$372M |
ASND, TCDAQ, CMTA, ALXN, ALEC
|
13F-HR |
5/15/2019, 04:24 PM |
Q4 2018 |
131 |
$5.41B |
+$705M |
-$1.06B |
-$350M |
TCDAQ, ASND, BIIB, CELG, BSX
|
13F-HR |
2/14/2019, 03:35 PM |
Q3 2018 |
148 |
$8.3B |
+$1.05B |
-$1.11B |
-$57.4M |
ALXN, TCDAQ, BIIB, VRTX, BSX
|
13F-HR |
11/14/2018, 03:07 PM |
Q2 2018 |
146 |
$8.37B |
+$1.5B |
-$1.11B |
+$392M |
ALXN, BIIB, TCDAQ, BSX, VRTX
|
13F-HR |
8/14/2018, 04:01 PM |
Q1 2018 |
141 |
$8.07B |
+$1.8B |
-$11.6B |
-$9.84B |
ALXN, REGN, VRTX, MRK, BIIB
|
13F-HR |
5/15/2018, 04:14 PM |
Q4 2017 |
130 |
$7.78B |
+$522M |
-$2.19B |
-$1.67B |
BIIB, ALXN, REGN, CELG, VRTX
|
13F-HR |
2/14/2018, 03:31 PM |
Q3 2017 |
143 |
$10.5B |
+$1.12B |
-$539M |
+$577M |
ALXN, BIIB, CELG, BSX, MRK
|
13F-HR |
11/14/2017, 04:19 PM |
Q2 2017 |
138 |
$9.54B |
+$1.5B |
-$689M |
+$809M |
ALXN, CELG, BIIB, BSX, MRK
|
13F-HR |
8/14/2017, 04:27 PM |
Q1 2017 |
136 |
$8.82B |
+$1.06B |
-$775M |
+$289M |
ALXN, BIIB, CELG, BSX, MRK
|
13F-HR |
5/15/2017, 04:17 PM |
Q4 2016 |
131 |
$7.85B |
+$1.24B |
-$752M |
+$486M |
ALXN, BIIB, CELG, BSX, AMGN
|
13F-HR |
2/14/2017, 03:25 PM |
Q3 2016 |
139 |
$8.76B |
+$1.15B |
-$2.12B |
-$967M |
BIIB, BSX, AMGN, ALXN, CELG
|
13F-HR |
11/14/2016, 03:27 PM |
Q2 2016 |
137 |
$9.58B |
+$1.27B |
-$1.08B |
+$187M |
BSX, AMGN, ABBV, BMY, BIIB
|
13F-HR |
8/15/2016, 04:16 PM |
Q1 2016 |
140 |
$9.5B |
+$1.09B |
-$539M |
+$553M |
BMY, HCA, AMGN, BSX, ABBV
|
13F-HR |
5/16/2016, 04:20 PM |
Q4 2015 |
129 |
$11B |
+$1.32B |
-$697M |
+$623M |
BMY, AMGN, BSX, AGN, BIIB
|
13F-HR |
2/16/2016, 03:24 PM |
Q3 2015 |
130 |
$9.9B |
+$1.13B |
-$575M |
+$556M |
BMY, HCA, AMGN, BSX, AGN
|
Restatement |
11/18/2015, 03:02 PM |
Q2 2015 |
1 |
$1.66M |
|
|
|
BONE
|
New Holdings |
8/20/2015, 02:30 PM |
Q2 2015 |
136 |
$11.9B |
+$2.37B |
-$1.01B |
+$1.36B |
BIIB, BMY, AGN, HCA, ABBV
|
13F-HR |
8/14/2015, 04:22 PM |
Q1 2015 |
135 |
$11.7B |
+$1.62B |
-$1.03B |
+$585M |
BMY, BIIB, AMGN, B108PS, CELG
|
13F-HR |
5/15/2015, 04:31 PM |
Q4 2014 |
131 |
$10.5B |
+$1.09B |
-$439M |
+$655M |
BIIB, BMY, AMGN, CELG, GILD
|
13F-HR |
2/13/2015, 03:13 PM |
Q3 2014 |
128 |
$9.4B |
+$1.98B |
-$543M |
+$1.44B |
GILD, BIIB, BMY, AMGN, ICPT
|
13F-HR |
11/14/2014, 03:15 PM |
Q2 2014 |
131 |
$8.48B |
+$1.13B |
-$587M |
+$540M |
ICPT, BMY, BIIB, ABBV, GILD
|
13F-HR |
8/14/2014, 04:23 PM |
Q1 2014 |
139 |
$8.12B |
+$1.38B |
-$774M |
+$606M |
ICPT, GILD, BIIB, BMY, RLYP
|
13F-HR |
5/15/2014, 04:26 PM |
Q4 2013 |
119 |
$6.79B |
|
|
|
GILD, BIIB, CELG, BMY, AMGN
|
13F-HR |
2/14/2014, 03:25 PM |